Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_365c4c63a45bc6c3b5cd6d8ac065baad |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-2812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-2837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0464 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-0427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00004 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-0682 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-0643 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-128 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-08 |
filingDate |
2005-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2ae679c819c02c2ca84c7f5fccc3a34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1389030e6d156aa4685a124d25ff880 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de696dde0420d3cdd3df68f27d73d895 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bca493b97a1d1cbedc1caab9668e2ab |
publicationDate |
2007-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1778100-A1 |
titleOfInvention |
Uterine artery occlusion staple |
abstract |
The invention is directed to an intravaginal staple for occluding a female patient’s uterine artery in the treatment of a uterine disorder such as fibroids, DUB, PPH, uterine bleeding after caesarian delivery and the like. The intravaginal staple includes an occluding bar having a pressure applying surface and at least one and preferably two tissue penetrating legs which are provided with protuberances which help to retain the staple leg within the penetrated tissue. At least part of the staple is preferably formed of bioabsorbable material so that it will in part self destruct at a preselected time period by separation of staple components caused by the bioabsorption of a bioabsorbable portion of the staple. The staple deployment system may be provided with elongated handles and staple deploying mechanisms on the distal ends of the handles to drive the legs of the staple into the tissue bundle about the uterine artery so that pressure applied by the occlusion bar occludes the uterine artery. |
priorityDate |
2004-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |